New Horizons in the development of antiepileptic drugs: Innovative strategies.
about
Diverse mechanisms of antiepileptic drugs in the development pipelineMolecular targets for antiepileptic drug developmentRediscovery of nefopam for the treatment of neuropathic painMapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsyNew in vitro phenotypic assay for epilepsy: fluorescent measurement of synchronized neuronal calcium oscillationsThe mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsyDeveloping Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsiesCitrus aurantium increases seizure latency to PTZ induced seizures in zebrafish thru NMDA and mGluR's I and II.Central Nervous System Effects of Iso-6-spectaline Isolated from Senna Spectabilis var. Excelsa (Schrad) in Mice.Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.High dosage of cannabidiol (CBD) alleviates pentylenetetrazole-induced epilepsy in rats by exerting an anticonvulsive effect.The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy.Enhancement of inhibitory neurotransmission and inhibition of excitatory mechanisms underlie the anticonvulsant effects of Mallotus oppositifolius.Stabilizing dendritic structure as a novel therapeutic approach for epilepsy.Neuroprotective effects of flavonoids extracted from licorice on kainate-induced seizure in mice through their antioxidant propertiesIntravenous Nefopam Reduces Postherpetic Neuralgia during the Titration of Oral Medications.Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?Anticonvulsive activity of (1S)-(-)-verbenone involving RNA expression of BDNF, COX-2, and c-fos.Seizing the moment for the future: the U.S. Anticonvulsant Screening Project.Nontraditional epilepsy treatment approaches.Herbs and spices: unexpected sources of antiepileptogenic drug treatments?Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy.Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy.Low-frequency stimulation inhibits epileptogenesis by modulating the early network of the limbic system as evaluated in amygdala kindling model.Design, synthesis, and anticonvulsant activity evaluation of 4-(3-alkoxy-phenyl)-2,4-dihydro-[1,2,4]triazol-3-ones.Synthesis and pharmacological investigation of 2-(4-dimethylaminophenyl)-3,5-disubstituted thiazolidin-4-ones as anticonvulsants.Coenzyme q10 ameliorates neurodegeneration, mossy fiber sprouting, and oxidative stress in intrahippocampal kainate model of temporal lobe epilepsy in rat.Synthesis and pharmacological evaluation of novel 1'-[2-(difluoromethoxy)benzyl]-2'H,5'H-spiro[8-azabicyclo[3.2.1]octane-3,4'-imidazolidine]-2',5'-diones and their derivatives.Validated HPLC Method for Quantification of Pregabalin in Human Plasma Using 1-Fluoro-2,4-dinitrobenzene as Derivatization Agent
P2860
Q24675330-0DB91738-5B06-44A2-B0E6-FC215F15AC99Q24683346-38BB0549-0516-4A25-91C3-03E239C6ACAAQ26998691-46AACFDA-E077-4914-ACEB-E4011801D0A5Q28480776-50F76E4D-D13B-426D-B546-3EEAE0118345Q28538488-F623BE66-3302-49DF-933C-094E1DCB9053Q28579751-E848460F-65B2-443F-9BCB-BBC843F715BBQ33805859-EBC8F20D-317D-4F2B-A43B-608ED5B15478Q34498303-158B3304-73B2-4080-BAD9-0A0B477B10AAQ35082329-4F03233C-3C8F-42FA-A916-C30703F94DCDQ35174115-D8634D47-19E4-40A9-8E2C-7941543E99B5Q35652804-C6505180-EF52-4053-B673-F2F73346ED7DQ35958755-375CB18E-3953-482D-B69B-96EBE4AA35E1Q36794851-BCE063E5-5577-4CB8-8A2A-077A6F6E8301Q37058186-00C91E66-40FB-49EB-8B20-9E5B286B4C1AQ37174044-1AB59D8E-82E8-40A2-AD63-8CB0E31BDA41Q37312940-8AE7BB58-9842-4752-AE9B-D18AE7222480Q37521631-3DAFF9D2-89D3-440C-910D-EF5CE68F66B4Q37603072-B6AA37FD-3927-4083-8139-8BEF5B8A93BBQ38747432-50E1FE79-8938-483B-B027-D37E64872F84Q39543552-A148FB52-9E23-4103-B922-854F200284F7Q42378944-75BD6795-6ED7-4E89-9915-7C1A0E9CB41DQ42928895-4D63C706-BBB7-4481-9110-DBD4A1F06B9DQ43854494-85A99F11-BF0D-4173-8C2D-9EBB9243DE25Q43990535-BBC2BF7F-CB4A-4EF5-9D54-338B024EB5BCQ43995549-7A6CA9D2-E1A7-4572-ACE6-5E26E2011693Q44033948-8C53D7E9-EB2C-4362-8EBB-CBF7F4295276Q48143337-D84004D5-8454-4D2C-BC17-91F459A558C7Q48364422-CD0DE8B0-D2F0-42DD-97D3-217ACF18BE02Q48367385-4D6D1EA3-13C8-4FEA-B4FB-5981150FF3ACQ59036798-5FF0F1CE-D3B6-404E-8055-154C19FB2C16
P2860
New Horizons in the development of antiepileptic drugs: Innovative strategies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
New Horizons in the development of antiepileptic drugs: Innovative strategies.
@en
type
label
New Horizons in the development of antiepileptic drugs: Innovative strategies.
@en
prefLabel
New Horizons in the development of antiepileptic drugs: Innovative strategies.
@en
P2860
P1433
P1476
New Horizons in the development of antiepileptic drugs: Innovative strategies.
@en
P2093
Dieter Schmidt
Wolfgang Löscher
P2860
P304
P356
10.1016/J.EPLEPSYRES.2006.03.014
P577
2006-06-01T00:00:00Z